Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Genscript Biotech (GNNSF) vs. Competitors

23 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
GNNSFGenscript Biotech$3.83$8.85B-12.9782.24%Strong BuyUnlock the GNNSF analyst price target with TipRanks PremiumGNNSFUnlock the GNNSF top-analyst price target with TipRanks Premium
HK:2269Wuxi Biologics (Cayman)HKD 46.74HKD 192.44B32.8335.56%Strong BuyUnlock the HK:2269 analyst price target with TipRanks PremiumGNNSF vs HK:2269Unlock the HK:2269 top-analyst price target with TipRanks Premium
HK:3759Pharmaron Beijing Co., Ltd. Class HHKD 28.10HKD 82.53B42.8616.40%Strong BuyUnlock the HK:3759 analyst price target with TipRanks PremiumGNNSF vs HK:3759Unlock the HK:3759 top-analyst price target with TipRanks Premium
HK:1521Frontage Holdings Corp.HKD 2.08HKD 4.23B50.8690.37%―Unlock the HK:1521 analyst price target with TipRanks PremiumGNNSF vs HK:1521Unlock the HK:1521 top-analyst price target with TipRanks Premium
HK:1873Viva Biotech HoldingsHKD 1.26HKD 2.62B13.04-42.20%―Unlock the HK:1873 analyst price target with TipRanks PremiumGNNSF vs HK:1873Unlock the HK:1873 top-analyst price target with TipRanks Premium
HK:6821Asymchem Laboratories (Tianjin) Co., Ltd. Class HHKD 118.70HKD 60.08B44.6740.72%Strong BuyUnlock the HK:6821 analyst price target with TipRanks PremiumGNNSF vs HK:6821Unlock the HK:6821 top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%200%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
GNNSFGenscript Biotech3.831.5467.04%
HK:2269Wuxi Biologics (Cayman)46.7414.3844.44%
HK:3759Pharmaron Beijing Co., Ltd. Class H28.106.0327.32%
HK:1521Frontage Holdings Corp.2.081.0193.93%
HK:1873Viva Biotech Holdings1.26-0.81-39.13%
HK:6821Asymchem Laboratories (Tianjin) Co., Ltd. Class H118.7039.4549.78%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts